Search Results 1201-1210 of 11233 for Antifungal Resistance

1. A Study to Analyze the Roles of Dendritic Cells and B Cells in the Pathogenesis of IgA Nephropathy (IgAN) - Mayo Clinic

   Subjects who have a current acute viral, bacterial, or fungal infection. Subjects diagnosed with the Human Immunodeficiency Virus (HIV), or who have tested ...

2. Study To Evaluate CCS1477 In Haematological Malignancies - Mayo Clinic

   This is also accompanied by an increase in myeloid differentiation in AML cells. CCS1477 has significant anti-tumour activity as a monotherapy in xenograft ...

3. Hidradenitis Suppurativa Clinical Trials - Mayo Clinic Research

   The primary objective of this trial is to assess the long-term safety of spesolimab in patients with HS who have completed the 1368-0052 PoCC trial and are ...

4. Clinical trials - Oncology (Medical)

   This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal ...

5. Alpha-1-antitrypsin deficiency

   Learn about alpha-1 antitrypsin deficiency. American Lung Association. https://www.lung.org/lung-health-diseases/lung-disease-lookup/alpha-1-antitrypsin- ...

6. A Study Of Oral Ozanimod As Maintenance Therapy For Moderately-to-Severely Active Crohn's Disease - Mayo Clinic

   The purpose of this study is to demonstrate the effectiveness of ozanimod compared to placebo on the maintenance of clinical remission and endoscopic response.

7. Phase II Study To Assess AFM13 In Patients With R/R CD30-positive T-cell Lymphoma Or Transformed Mycosis Fungoides - Mayo Clinic

   The purpose of this study is to learn about the effects of a research medicine called AFM13 and to see how well AFM13 is tolerated. Participation eligibility.

8. A Open Label Study Of The Efficacy And Safety Of PD0332991 A Selective Inhibitor Of The Cyclin Dependent Kinases 4 And 6 In Patients With Recurrent Ovarian Cancer Demonstrating Rb-proficiency And Low P16 Expression - Mayo Clinic

   Patients with platinum-sensitive or platinum-resistant disease defined by recurrence or progression of disease > 6 months or ≤ than 6 months after completion ...

9. ALPN-202 With PD-1 Inhibition In Advanced Malignancies - Mayo Clinic

   that is refractory or resistant to standard therapy; or; for which standard or curative therapy is not available. Have received ≥ 2 prior systemic anti ...

10. Non Hodgkin Clinical Trials

    ... resistant chronic lymphocytic leukemia or small lymphocytic lymphoma. ... Continuation in the study is not contingent on continuation of Valchlor. Exploring ...